Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa
about
Infliximab leads to a rapid but transient improvement in endothelial function in patients with primary systemic vasculitisClinically Apparent Arterial Thrombosis in Persons with Systemic Vasculitis.Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis.Endothelial cells, fibroblasts and vasculitisMacrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.Accelerated atherosclerosis in patients with Wegener's granulomatosisA model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitisAccelerated atherosclerosis in inflammatory rheumatic diseases.Large artery stiffness and inflammation.Endotoxin-induced and vaccine-induced systemic inflammation both impair endothelium-dependent vasodilation, but not pulse wave reflection.Endothelial function and its assessment.Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment.Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics.Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa.Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future.Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study.[Managing comorbidities of inflammatory rheumatic diseases].Mortality in Wegener's granulomatosis: a bimodal pattern.Cell-derived microparticles contain caspase 3 in vitro and in vivo.Decreased flow-mediated dilatation with increased arterial stiffness and thickness as early signs of atherosclerosis in polymyositis and dermatomyositis patients.Avoidance of Harm From Treatment for ANCA-Associated Vasculitis.Assessment of autonomic function in a cohort of patients with ANCA-associated vasculitis.Accelerated atherosclerosis in ANCA-associated vasculitis.Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies.Impaired endothelial function in systemic lupus erythematosus.Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine.
P2860
Q33229786-B93E07B6-3B5B-46D9-9702-E30C7A0472D2Q33872858-AA7EEFC1-140E-400D-8631-B81E2447F13DQ34201979-F802CBA4-71D2-48B2-8F7A-554C94BF3635Q35058025-3A2E33AD-36A2-433E-AC03-95648BDAEA7CQ35367857-849E7588-C9CB-434D-B51F-6AB1DE8DCD8CQ35553196-AB0EF692-9896-4AAC-B0B5-9DE5DBB77592Q35555500-E0E08EF5-372E-4913-91D8-A59A05BCF3FBQ35878676-5159E652-09DA-4278-AA2D-1DE4551CC0A7Q35932689-D9AF4DC2-CBAE-4EB7-A6CD-FE3372031F7CQ36007909-DD713C69-EF5D-4EDE-877F-8D4E59255DCEQ36136279-E1EB78C3-409F-46CC-B44D-33A859C7E807Q36300017-E3C48AD1-9E92-4B35-9CC0-DD9F08BF4C7BQ36401936-1DBF02E2-F602-4C9F-923B-34AF9A5CB6BCQ37358089-BDA5E9A1-52EC-4DEB-BC89-36A52996CDBBQ38365744-B4DA5CFE-9019-4326-BD98-37D9318232D5Q38877243-5C2043E8-5DAC-4D87-8EF3-FCF5E4AC0A99Q39201920-37917A17-04AA-4A48-B8A1-D18D7464FD31Q43251970-DF49EF98-4AC0-4064-96E5-8AA2C71DA0C5Q44393048-3224D0AB-3A3E-4593-919F-4257FE923B49Q44964147-AFB3C35E-FC45-4F79-A723-7BF7C91851F4Q46470673-E27C1EBF-2E57-46CB-A2CD-B993D7EE566EQ46937303-C4861802-300C-4044-AB82-812A8E9A1660Q47105115-04247B15-F8EA-4B37-960F-DC08EDDBB3AAQ47991378-0D7271D0-962F-4595-AF4F-21350979E728Q48287381-990A3F53-BC24-43DC-9A91-D26CEE7DD943Q50065383-54DF9815-314F-42F8-8163-5EA82501EA95Q51758271-B3043ED3-5922-40D6-8EA6-7847A97ADD25Q54213155-7924079D-0EEE-4896-9119-AD2806CF2083
P2860
Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@ast
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@en
type
label
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@ast
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@en
prefLabel
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@ast
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@en
P2093
P2860
P356
P1476
Diffuse endothelial dysfunctio ...... litis and polyarteritis nodosa
@en
P2093
D M Carruthers
J M Gardner-Medwin
J Thambyrajah
R J Stevens
P2860
P304
P356
10.1136/ARD.62.2.162
P407
P577
2003-02-01T00:00:00Z